Company Filing History:
Years Active: 1976-1983
Title: Myron C. Rapkin: Innovator in Glucose Detection and Urobilinogen Control
Introduction
Myron C. Rapkin is a notable inventor based in Elkhart, Indiana, recognized for his contributions to medical diagnostics. With a total of seven patents to his name, Rapkin has made significant advancements in the field of biochemical testing.
Latest Patents
Among his latest innovations is the "Method and composition for urobilinogen control standard." This patent describes a composition that includes a substituted indole and a nonionic detergent solution, which reacts with p-diethylaminobenzaldehyde and hydrochloric acid. The method involves dissolving the substituted indole in a selected nonionic detergent and diluting the solution to a predetermined level. Additionally, he developed a "Method and device for detecting glucose concentration." This invention provides a method and test device for determining glucose levels in samples containing 1/2 to 5 percent glucose. The device incorporates urea-formaldehyde resin in a carrier matrix, which is then impregnated with an enzymatic testing composition that includes glucose oxidase, a peroxidatively-active compound, and a chromogen.
Career Highlights
Myron C. Rapkin has spent a significant portion of his career at Miles Laboratories, Inc., where he has been instrumental in developing innovative diagnostic methods. His work has contributed to advancements in medical testing, particularly in glucose detection and urobilinogen control.
Collaborations
Rapkin has collaborated with notable colleagues, including David L. Tabb and Leonard P. Fenocketti, enhancing the impact of his inventions through teamwork and shared expertise.
Conclusion
Myron C. Rapkin's contributions to the field of medical diagnostics through his patents demonstrate his innovative spirit and dedication to improving healthcare. His work continues to influence the development of diagnostic technologies.